Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.
1. The National Pharmaceutical Pricing Authority has increased the ceiling prices of Anti-Tetanus Immunoglobulin 250 International Units and 500 International Units injections by 50 percent exercising its extraordinary powers. The revision follows concerns over rising production costs and aims to ensure continued availability of these essential life-saving medicines.
Source: short-url.cc/1ymqX
2. India’s central food authority, FSSAI, has reportedly issued show-cause notices to eight food companies in India. One such notice was issued for deceptive branding. This Notice was issued because a brand used the claim “plant-based vegan” on the packaging which was not approved under FSSAI license obtained. Such claims have higher chances of misleading the consumers by using marketing tactics to create false impressions of the brand.
Source: short-url.cc/1ymr2
3. India’s central food authority, FSSAI, has reportedly advised Food Business Operators (FBOs) to immediately discontinue the use of metallic pins, staples, and wires in food packaging materials, citing potential risks of physical contamination and consumer injury. The regulator has urged businesses to review their packaging processes and adopt safer alternatives such as food-grade adhesives, tapes, or other secure packaging methods that do not compromise food safety. The advisory forms part of FSSAI’s ongoing efforts to strengthen food safety practices and reduce the risk of foreign matter contamination across the food supply chain.
Source: short-url.cc/1sRhw
4. The Central Drugs Standard Control Organisation (CDSCO) mandates that all manufacturers and importers of hair colour cosmetics strictly adhere to the Cosmetics Rules, 2020, and applicable Bureau of Indian Standards (BIS). To safeguard public health, stakeholders must ensure absolute compliance with statutory labelling requirements, ingredient restrictions, and mandatory caution statements. Furthermore, any alterations to a product’s composition, quality specifications, or label must be formally reported to the appropriate Central or State Licensing Authority.
Source: short-url.cc/1sRhD
5. The National Pharmaceutical Pricing Authority (NPPA) has revised upward the ceiling prices of BCG, Measles Rubella and Measles vaccines pursuant to a review order. The change reflects the Department of Pharmaceuticals’ view that the 17.1% monopoly reduction should not apply to vaccines, supporting continued vaccine availability.
Source: short-url.cc/1ymqX